Short page
CJC-1295 w/o DAC

Specification
| Name | CJC-1295 w/o DAC |
|---|---|
| Catalog sizes | 10 mg |
| Adopted bacteriostatic water | 10 mg + 2.0 mL = 5 mg/mL |
Overview
CJC-1295 without DAC is, in the catalog, a 10 mg vial of a GHRH analog without the complex that lengthens action. The 2006 trial TRACE cites evaluated the DAC form, not this vial. It is not presented as the same material.
Mechanism under study
Without DAC, the secretagogue literature treats the analog as a shorter signal at the GHRH receptor. TRACE has not adopted a trial of its own for this presentation.
What published research has reported
No clinical trial of this without-DAC vial is cited. The reference for the DAC form is on that page, so the two materials are not mixed.
This version does not close a study list. No citation is invented.
Composition and mass
10 mg vial. Adopted bacteriostatic water: 2 mL (5 mg/mL). The figure comes from the arithmetic used for 10 mg of CJC-1295, not from a trial of this presentation alone.
Reconstitution
| mg | mL | mg/mL | |
|---|---|---|---|
| 10 | 2.0 | 5 | In the catalog |
Storage and handling
Lyophilized material cool, dry, and protected from light. Dissolved: 2–8 °C, not frozen, 28-day horizon.
Regulatory status
Research material. Not an approved medicine.